Lund, Sweden

Robert Zuban

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Robert Zuban - Innovator in Pharmaceutical Chemistry

Introduction

Robert Zuban is a notable inventor in the field of pharmaceutical chemistry. He has made significant contributions to the development of compounds that are useful in treating various medical conditions. His work focuses on innovative solutions that can improve patient outcomes.

Latest Patents

Robert Zuban holds a patent for the Tosylate Salt Of A 5-Pyrazolyl-2-Pyridone Derivative, which is particularly useful in the treatment of Chronic Obstructive Pulmonary Disease (COPD). The patent details the compound 6-Methyl-5-(I-methyl-1H-pyrazol-5-yl)-N-{ [5-(methylsulfonyl)pyridin-2-yl]methyl }-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide 4-methylbenzenesulfonate. This invention includes processes for preparing the salt and a novel crystalline form, along with pharmaceutical compositions that utilize this form in therapy.

Career Highlights

Throughout his career, Robert Zuban has focused on the intersection of chemistry and medicine. His innovative approaches have led to advancements in drug formulations and therapeutic applications. Despite having no patents listed under his name, his contributions to the field are noteworthy.

Collaborations

Robert Zuban has worked alongside talented colleagues, including Marie-Lyne Alcaraz and Lars-Erik Briggner. Their collaborative efforts have enhanced the research and development of pharmaceutical compounds.

Conclusion

Robert Zuban's work exemplifies the importance of innovation in pharmaceutical chemistry. His contributions, particularly in the development of treatments for COPD, highlight the potential of chemical compounds in improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…